Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification-Reference-Cited by-同舟云学术

Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification

Published:2023-05-06 Issue:11 Volume:396 Page:3045-3059
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Yang Ye^ORCID,Yan Jiaoyan^ORCID,Huang Jian^ORCID,Wu Xiangyi^ORCID,Yuan Yan^ORCID,Yuan Yan^ORCID,Zhang Shu^ORCID,Mo Fei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-023-02510-9.pdf

Reference45 articles.

1. Burley SK, Bhikadiya C, Bi C et al (2021) RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res 49:D437–D451. https://doi.org/10.1093/nar/gkaa1038

2. Chen Z, Huang C, Ma T et al (2018) Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. Phytomedicine 43:37–45. https://doi.org/10.1016/j.phymed.2018.03.040

3. Chen Y, Li X, Xu J et al (2022) Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway. Bioengineered 13:3526–3536. https://doi.org/10.1080/21655979.2021.2018973

4. Cui Y, Li Q, Li H et al (2017) Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAGAP1 modulating the EGFR/JNK/ERERK signaling pathway. Onco Targets Ther 10:627–643. https://doi.org/10.2147/OTT.S125579

5. Cui X, Sun Y, Shen M et al (2018) Enhanced chemotherapeutic efficacy of paclitaxel nanoparticles co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy. ACS Appl Mater Interfaces 10:7821–7831. https://doi.org/10.1021/acsami.7b19183

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymol as adjuvant in oncology: molecular mechanisms, therapeutic potentials, and prospects for integration in cancer management;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-07